Pharmacoeconomic advantages of subcutaneous versus intravenous immunoglobulin treatment in a Canadian pediatric center

J Allergy Clin Immunol. 2013 Feb;131(2):585-7.e1-3. doi: 10.1016/j.jaci.2012.08.022. Epub 2012 Oct 2.
No abstract available

MeSH terms

  • Canada
  • Child
  • Cohort Studies
  • Cost-Benefit Analysis
  • Economics, Pharmaceutical
  • Female
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage*
  • Immunoglobulins, Intravenous / economics*
  • Immunologic Deficiency Syndromes / therapy
  • Injections, Intravenous
  • Injections, Subcutaneous
  • Male
  • Retrospective Studies

Substances

  • Immunoglobulins, Intravenous